Member Info for Doc83

Thanks Graham. I recall you talking at the AGM. Was so much information to take in, I knew we’d miss something!

Let’s hope we are indeed being used (in trials) this winter.

And thanks all for the kind comments. I’ve found the board hugely helpful/interesting since investing in SNG, so it’s nice to give a bit back, even if it is effectively just transcribing the AGM!

Thanks HPHQ. It was some effort and a very early start. But good for everyone to hopefully glean something from the AGM. Banging headache now… I promise nothing to do with the “few” pints of Doom Bar post AGM and debrief… ;)

We're basically there. Just waiting for Wigster to sign off one last bit... 2600 words :/

Hi JoeyDiamond - I didn’t see any recording equipment of any kind. But I may have missed it. My impression was that there will be nothing like that provided.

Tommy - I think that’s a very fair assessment. It went on until around 11.15am, with most of that for Q&A for those in the room…. Got to give them full credit for that. They were peppered non stop with questions and I thought answered most of them well. A few responses I particularly liked, and I tend to agree that Synairgen’s future is far from done.

Mani - correct.

Next year, providing Synairgen is still alive, we’ll have to get a few more of us along.

Nessab - was that you there today, or someone else? There sounded like there were a few familiar posters there, but I did expect plenty more to turn up than did.

Hi Aether, apologies. It is not intentional.

We want to put a detailed write up together of everything discussed. We have detailed notes and it would be impossible to write it all on via phone.

It will be as impartial as possible, with more of the facts than personal opinion. But I am happier now than before I went in, albeit this is going to be a longer journey than we had all initially hoped.

Aether - yes, I asked a very direct question. Full write up to come tonight or tomorrow once I’m back from London.

Hi all, just got out of the AGM. I counted approximately 16 investors only, plus a few of the Synairgen team such as Brooke who were sat with everyone.

I’m just having a thorough debrief with a fellow LSE member and will do a full write up if not this evening, tomorrow.

Got to shake hands with Sir Stephen Holgate and a brief one to one chat with RM and Simon Shaw. I personally found it a fascinating meeting. But in summary, I’m happy to hold my shares.

More to come from me as soon as I can write it up properly.

HPHQ - have you had any confirmation at all from HL that you’re down to attend? They usually have to send a letter to the registrar. If so, I reckon you’d be ok with ID and account details, providing the registrar know.

Right, bed for me. 5am start… ugh.

Niceday - realistically, how else can they answer that but “yes”?!

Manifesto - yes, we would really need two or more potential partners fighting over us. Because if not, I maintain our position is weak. MrCosts is right… we are now reliant on others, and that is usually not a good place to find yourself.

It is most likely that tomorrow will be a non event, and as a result the SP could fall (it already is!).

But we know we are waiting for news on ACTIV P2 data and new trials. So if there's no news tomorrow we shouldn't necessarily panic. What I'm really after tomorrow is to find out if the current management team have the ability to take Synairgen forward and what their own plans/thoughts are for the future.

Tommy says questions about money running out are being answered by the BOD saying they'll JV/partner up. But as mentioned earlier, we seem in a very weak position to be negotiating any JV terms. Any partner who don't like our terms can tell us to go on our own, knowing we can't afford it. I may be wrong...

There’s so many questions I could ask Synairgen, but I really want to know their thoughts on:

Polygon - we all seems fixated on them and their buying up of SNG shares, and rightly so. Heading up towards 30%, they are now extremely relevant to SNG’s future, so what are the board’s thoughts?

JV/Partnership - mentioned previously by RM, is this realistic? And if so, are we not in a perilously weak negotiating position, because any potential partner could threaten and say to us to go it alone ourselves, knowing we cannot afford this?

Recent hires - we hired a lot of expensive people when looking to scale up production on the back of a successful P3. This didn’t happen, so what are the plans for these people?

Superbly done, Wigster77.

“I remember reading posts saying that incorrect amount of doses were given eg. not the correct number per day, or not starting on day 1 etc. If true, then why no compensation from the trial administrators…”

Fantastic question. 10’s of £millions spent on a trial for a third party(s) to mess it up. Compensation sounds fair to me.

Tommy - if the numbers are good, that it could be saving lives (or well on its way to being proven in a larger P3 trial) do you agree it’s poor form for it to have dragged on so long? We’ll be a year on from P2 completion and no sign of it being progressed despite the urgent need for it.

Feef56 - let’s pretend the ACTIV P2 trial had similar levels of efficacy as our hospitalised patients P2 trial in July 2020, where there was an incredible 79% reduction in developing severe diseases, for the ACTIV team to have not still progressed it would make them morally bankrupt. If it was so good that it could be saving lives and to just leave it in no man’s lands…

That’s why my guess is that the numbers are good. But not that good.

Again, I hope I’m wrong and we saw 80%+ improvements and the NIH have dropped a moral clanger.

Other possibility is that P2 results were merely average (like SAB’s), hence no rush to get it on another trial and/or trying to find if there’s some trial they can construct that might prove it works.

Clearly I hope this is not the case!

Equates to 34p on current exchange rate. So not near off. It’s also only 150 shares volume!